574 related articles for article (PubMed ID: 35224605)
21. Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines.
Naveed Z; Li J; Wilton J; Spencer M; Naus M; Velásquez García HA; Kwong JC; Rose C; Otterstatter M; Janjua NZ;
J Am Coll Cardiol; 2022 Nov; 80(20):1900-1908. PubMed ID: 36357091
[TBL] [Abstract][Full Text] [Related]
22. Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature.
Lane S; Yeomans A; Shakir S
BMJ Open; 2022 May; 12(5):e059223. PubMed ID: 35613761
[TBL] [Abstract][Full Text] [Related]
23. Assessing the temporal and cause-effect relationship between myocarditis and mRNA COVID-19 vaccines. A retrospective observational study.
Bianchi FP; Rizzi D; Daleno A; Stefanizzi P; Migliore G; Tafuri S
Int J Infect Dis; 2024 Apr; 141():106960. PubMed ID: 38365084
[TBL] [Abstract][Full Text] [Related]
24. Increased risk of myocarditis and pericarditis and reduced likelihood of severe clinical outcomes associated with COVID-19 vaccination: a cohort study in Lombardy, Italy.
Corrao G; Franchi M; Cereda D; Bortolan F; Leoni O; Vignati E; Pavesi G; Gori A
BMC Infect Dis; 2022 Nov; 22(1):844. PubMed ID: 36371165
[TBL] [Abstract][Full Text] [Related]
25. Risks of Myocarditis and Pericarditis Following Vaccination with SARS-CoV-2 mRNA Vaccines in Japan: An Analysis of Spontaneous Reports of Suspected Adverse Events.
Kobayashi H; Fukuda S; Matsukawa R; Asakura Y; Kanno Y; Hatta T; Saito Y; Shimizu Y; Kawarasaki S; Kihara M; Kinoshita N; Umeda H; Noda T; Imamura T; Nishioka Y; Yamaguchi T; Hayashi S; Iguchi T
Ther Innov Regul Sci; 2023 Mar; 57(2):329-342. PubMed ID: 36310329
[TBL] [Abstract][Full Text] [Related]
26. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection.
Patone M; Mei XW; Handunnetthi L; Dixon S; Zaccardi F; Shankar-Hari M; Watkinson P; Khunti K; Harnden A; Coupland CAC; Channon KM; Mills NL; Sheikh A; Hippisley-Cox J
Nat Med; 2022 Feb; 28(2):410-422. PubMed ID: 34907393
[TBL] [Abstract][Full Text] [Related]
27. Myocarditis after vaccination against covid-19.
Gellad WF
BMJ; 2021 Dec; 375():n3090. PubMed ID: 34916217
[No Abstract] [Full Text] [Related]
28. Comparative assessment of myocarditis and pericarditis reporting rates related to mRNA COVID-19 vaccines in Europe and the United States.
Hatziantoniou S; Anastassopoulou C; Lazaros G; Vasileiou K; Tsioufis C; Tsakris A
Expert Rev Vaccines; 2022 Nov; 21(11):1691-1696. PubMed ID: 35815358
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination.
Chua GT; Kwan MYW; Chui CSL; Smith RD; Cheung ECL; Ma T; Leung MTY; Tsao SSL; Kan E; Ng WKC; Chan VCM; Tai SM; Yu TC; Lee KP; Wong JSC; Lin YK; Shek CC; Leung ASY; Chow CK; Li KW; Ma J; Fung WY; Lee D; Ng MY; Wong WHS; Tsang HW; Kwok J; Leung D; Chung KL; Chow CB; Chan GCF; Leung WH; To KKW; Yuen KY; Lau YL; Wong ICK; Ip P
Clin Infect Dis; 2022 Sep; 75(4):673-681. PubMed ID: 34849657
[TBL] [Abstract][Full Text] [Related]
30. Risk of myopericarditis following COVID-19 mRNA vaccination in a large integrated health system: A comparison of completeness and timeliness of two methods.
Sharff KA; Dancoes DM; Longueil JL; Johnson ES; Lewis PF
Pharmacoepidemiol Drug Saf; 2022 Aug; 31(8):921-925. PubMed ID: 35404496
[TBL] [Abstract][Full Text] [Related]
31. Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series.
Fazlollahi A; Zahmatyar M; Noori M; Nejadghaderi SA; Sullman MJM; Shekarriz-Foumani R; Kolahi AA; Singh K; Safiri S
Rev Med Virol; 2022 Jul; 32(4):e2318. PubMed ID: 34921468
[TBL] [Abstract][Full Text] [Related]
32. Development of myocarditis and pericarditis after COVID-19 vaccination in children and adolescents: A systematic review.
Fatima M; Khan MHA; Ali MS; Osama M; Cheema HA; Ahmed A; Nisar A; Murad MW; Farooq H; Aemaz Ur Rehman M; Swed S; Akbar UA
Clin Cardiol; 2023 Mar; 46(3):243-259. PubMed ID: 36594165
[TBL] [Abstract][Full Text] [Related]
33. [2022 Update on myocarditis and pericarditis following COVID-19 vaccination. Expert Opinion of the Italian Society of Cardiology].
Sinagra G; Porcari A; Merlo M; Fabris E; Imazio M; Barillà F; Basso C; Ciccone MM; Curcio A; Mancone M; Mercuro G; Muscoli S; Nodari S; Pedrinelli R; Spaccarotella C; Filardi PP; Indolfi C
G Ital Cardiol (Rome); 2022 Jun; 23(6):408-413. PubMed ID: 35674028
[TBL] [Abstract][Full Text] [Related]
34. Myocarditis and pericarditis after COVID-19 messenger RNA vaccines.
Goldman RD
Can Fam Physician; 2022 Jan; 68(1):17-18. PubMed ID: 35063975
[TBL] [Abstract][Full Text] [Related]
35. Myocarditis and Pericarditis After COVID-19 mRNA Vaccination: Practical Considerations for Care Providers.
Luk A; Clarke B; Dahdah N; Ducharme A; Krahn A; McCrindle B; Mizzi T; Naus M; Udell JA; Virani S; Zieroth S; McDonald M
Can J Cardiol; 2021 Oct; 37(10):1629-1634. PubMed ID: 34375696
[TBL] [Abstract][Full Text] [Related]
36. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
Gargano JW; Wallace M; Hadler SC; Langley G; Su JR; Oster ME; Broder KR; Gee J; Weintraub E; Shimabukuro T; Scobie HM; Moulia D; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(27):977-982. PubMed ID: 34237049
[TBL] [Abstract][Full Text] [Related]
37. Incidence, Clinical Presentation, and Management of Myocarditis following mRNA-Based Covid-19 Vaccines: A Brief Report.
Saeed S; Käsk L; Rajani R; Larsen TH
Cardiology; 2022; 147(4):406-412. PubMed ID: 35104821
[TBL] [Abstract][Full Text] [Related]
38. A review of COVID-19 vaccination and the reported cardiac manifestations.
Ho JSY; Sia CH; Ngiam JN; Loh PH; Chew NWS; Kong WK; Poh KK
Singapore Med J; 2023 Sep; 64(9):543-549. PubMed ID: 34808708
[TBL] [Abstract][Full Text] [Related]
39. Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis.
Alami A; Krewski D; Farhat N; Mattison D; Wilson K; Gravel CA; Farrell PJ; Crispo JAG; Haddad N; Perez-Lloret S; Villeneuve PJ
BMJ Open; 2023 Jun; 13(6):e065687. PubMed ID: 37339840
[TBL] [Abstract][Full Text] [Related]
40. Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.
Oster ME; Shay DK; Su JR; Gee J; Creech CB; Broder KR; Edwards K; Soslow JH; Dendy JM; Schlaudecker E; Lang SM; Barnett ED; Ruberg FL; Smith MJ; Campbell MJ; Lopes RD; Sperling LS; Baumblatt JA; Thompson DL; Marquez PL; Strid P; Woo J; Pugsley R; Reagan-Steiner S; DeStefano F; Shimabukuro TT
JAMA; 2022 Jan; 327(4):331-340. PubMed ID: 35076665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
